Results 11 to 20 of about 251,345 (303)

Efficacy of Oral Vaccine against Classical Swine Fever in Wild Boar and Estimation of the Disease Dynamics in the Quantitative Approach

open access: yesViruses, 2021
Classical swine fever virus (CSFV) in the wild boar population has been spreading in Japan, alongside outbreaks on pigs, since classical swine fever (CSF) reemerged in September 2018.
Enkhbold Bazarragchaa   +6 more
doaj   +1 more source

A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus

open access: yesViruses, 2022
Canine Distemper Virus (CDV) is a fatal and highly contagious pathogen of multiple carnivores. While injectable vaccines are very effective in protecting domestic animals, their use in the wild is unrealistic.
Xiang Du   +4 more
doaj   +1 more source

Gastrointestinal Involvement in SARS-CoV-2 Infection

open access: yesViruses, 2022
SARS-CoV-2 has evolved into a virus that primarily results in mild or asymptomatic disease, making its transmission more challenging to control. In addition to the respiratory tract, SARS-CoV-2 also infects the digestive tract.
Tsung-Hsien Chen   +3 more
doaj   +1 more source

BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis - review

open access: yesMemorias do Instituto Oswaldo Cruz, 2005
The vaccine Bacillus of Calmette Guérin (BCG) was originally developed in France as an oral vaccine against tuberculosis. The oral use of this vaccine was replaced by the parenteral route in almost all countries after the Lubeck disaster.
Thereza Christina Benévolo-de-Andrade   +3 more
doaj   +1 more source

The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees? [PDF]

open access: yes, 2017
Could new oral vaccine technologies protect endangered wildlife against a rising tide of infectious disease? We used captive chimpanzees to test oral delivery of a rabies virus (RABV) vectored vaccine against Ebola virus (EBOV), a major threat to wild ...
Goetzmann, Jason E.   +5 more
core   +2 more sources

Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio

open access: yesFrontiers in Immunology, 2022
Cyprinid herpesvirus 2 (CyHV-2) causes herpesviral hematopoietic necrosis (HVHN) disease outbreaks in farmed Cyprinid fish, which leads to serious economic losses worldwide.
Zhao-Ran Dong   +10 more
doaj   +1 more source

Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): Vaccination using inactivated bacteria is one of the most effective ways to protect against EHEC infection. Escherichia coli O157:H7 infections are mainly influenced by Shiga toxins (Stx) and attaching/effacing factors.
Nasim Arshadi   +3 more
doaj   +1 more source

Oral Vaccines Against Cholera [PDF]

open access: yesClinical Infectious Diseases, 2011
The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
Sunheang, Shin   +3 more
openaire   +2 more sources

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. [PDF]

open access: yes, 2015
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve this aim, it is essential to block viral replication in individuals via induction of a robust mucosal immune response. Although it has long been recognized
Anis E   +16 more
core   +3 more sources

Evaluation of Microparticulate Ovarian Cancer Vaccine via Transdermal Route of Delivery [PDF]

open access: yes, 2016
Ovarian cancer is the fifth most commonly occurring malignancy in women, with the highest mortality rate among all the gynecological tumors. Microparticulate vaccine can serve as an immunotherapeutic approach with a promising antigenic delivery system ...
Akalkotkar, Archana   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy